Demonstrating preclinical efficacy of AUY922, a novel Hsp90 inhibitor, alone and in combination with standard chemotherapy or radiation in esophageal adenocarcinoma.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Kosovec, J; Rotoloni, C; Zaidi, AH; Komastu, Y; Kelly, L; Matsui, D; Waheed, A; Hoppo, T; Jobe, BA
Published Date
- May 20, 2014
Published In
Volume / Issue
- 32 / 15_suppl
Start / End Page
- e13506 - e13506
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2014.32.15_suppl.e13506